What is the formula for calculating Pulmonary Vascular Resistance (PVR) in a patient with pulmonary hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Formula for Pulmonary Vascular Resistance (PVR)

The formula for calculating PVR is: PVR = (mean pulmonary artery pressure - pulmonary capillary wedge pressure) / cardiac output, expressed as Wood units. 1

Standard PVR Calculation

  • PVR = (mPAP - PCWP) / CO 1

    • mPAP = mean pulmonary artery pressure (mmHg)
    • PCWP = pulmonary capillary wedge pressure (mmHg)
    • CO = cardiac output (L/min)
    • Result expressed in Wood units (preferred) 2, 1
  • To convert Wood units to dynes·s·cm⁻⁵, multiply by 80 1

  • Normal PVR values are <2-3 Wood units 1

Required Measurements

Mean Pulmonary Artery Pressure (mPAP)

  • Must be measured directly via right heart catheterization—this is the gold standard and only validated method for accurate PVR determination 1
  • Measurements should be taken at end-expiration during spontaneous breathing, or at end-inspiration if mechanically ventilated 1

Pulmonary Capillary Wedge Pressure (PCWP/PAWP)

  • Obtained by wedging a balloon-tipped catheter into a small pulmonary arterial branch with the balloon inflated 1
  • The external pressure transducer must be zeroed at the mid-thoracic line 1
  • European guidelines use the term PAWP (pulmonary artery wedge pressure) interchangeably with PCWP 2, 1
  • PCWP serves as a validated surrogate for left atrial pressure in the absence of pulmonary vein obstruction 1
  • A PCWP >15 mmHg excludes the diagnosis of pre-capillary pulmonary arterial hypertension 2, 1

Cardiac Output (CO)

  • Measured in L/min, typically via thermodilution or Fick method 1
  • In patients with tricuspid regurgitation and right ventricular dilatation, thermodilution measurements can be erroneous, affecting all derived resistance calculations 1
  • Direct measurement of oxygen consumption (VO₂) is preferable to estimation, particularly in children <3 years of age, as the LaFarge equation can overestimate VO₂ and lead to underestimation of PVR 1

Indexed PVR (PVRI)

  • PVRI = PVR × body surface area (BSA) 1
  • Expressed as Wood units·m² (WU·m²) 1
  • Particularly important in pediatric populations where body size varies significantly 1

Clinical Thresholds

Diagnostic Criteria

  • PVR >3 Wood units defines pre-capillary pulmonary hypertension (2015 guidelines) 2, 1
  • PVR >2 Wood units defines pre-capillary pulmonary hypertension (2024 guidelines) 1
  • Must be accompanied by mPAP ≥25 mmHg and PAWP ≤15 mmHg for diagnosis of pulmonary arterial hypertension 2

Surgical Decision-Making

  • PVR >2.5 Wood units or PVRI >4 WU·m² is a contraindication for congenital heart disease shunt closure 1
  • Surgical repair is recommended when PVR is less than one-third of SVR 1
  • PVRI >6 WU·m² predicts poor outcomes in single ventricle patients undergoing cavopulmonary surgery 1
  • PVRI <6 WU·m² is an indicator for repair in children with structural heart disease (ASD, VSD, PDA) 1

Critical Pitfalls and Caveats

Measurement Timing and Conditions

  • Blood pH has a potent effect on pulmonary vascular tone—acidosis causes vasoconstriction while alkalosis causes vasodilation; awareness of arterial blood gas measurements during catheterization is critical 1
  • Measurements should be obtained under standardized conditions, as general anesthesia can lower systemic arterial blood pressure and affect resistance calculations 1
  • Volume status assessment in pulmonary hypertension patients is notoriously difficult, and non-invasive estimates of central venous pressures may be misleading, requiring direct central line measurement 1

PCWP Accuracy Issues

  • PCWP may overestimate the true transmitral gradient due to phase delay when compared to direct left ventricular pressure 1
  • Direct left atrial pressure or LVEDP measurement is recommended when left heart disease is the likely etiology, such as in patients with orthopnea or associated risk factors 1
  • During mechanical ventilation with high PEEP, calculating the transmural value of PCWP allows estimation of true left ventricular filling pressure 1
  • PCWP may be recorded with or without V-wave; this should be documented 1

Alternative Hemodynamic Parameter

  • The transpulmonary pressure gradient (TPG = mPAP - PCWP) provides valuable information about pulmonary vascular abnormality independent of calculated PVR 1
  • A TPG >6 mmHg suggests high risk for poor outcomes in cavopulmonary anastomosis 1

Echocardiographic Estimation Limitations

  • Echocardiographic estimation of pulmonary artery systolic pressure has limited positive predictive value (25-64%) for confirming pulmonary hypertension 1
  • While Doppler-derived formulas for PVR estimation show correlation with invasive measurements in research settings 3, 4, 5, echocardiographic estimation should not replace right heart catheterization for PVR calculation in clinical decision-making 1
  • Agreement between echocardiographic and invasive PVR is poor in patients with PVR >8 Wood units 4

References

Guideline

Calculation of Pulmonary and Systemic Vascular Resistance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Echocardiography based estimation of pulmonary vascular resistance in patients with pulmonary hypertension: a simultaneous Doppler echocardiography and cardiac catheterization study.

European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2011

Research

Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007

Related Questions

At what Pulmonary Vascular Resistance (PVR) level is right heart catheterization required in a patient with suspected or confirmed pulmonary arterial hypertension?
Which is correct to use, Pulmonary Capillary Wedge Pressure (PCWP), Pulmonary Artery Wedge Pressure (PAWP), or Pulmonary Artery Occlusion Pressure (PAOP), when calculating Pulmonary Vascular Resistance (PVR)?
How do you calculate pulmonary vascular resistance (PVR) versus systemic vascular resistance (SVR) and what factors do you consider?
What is the formula to calculate Pulmonary Vascular Resistance Index (PVRI)?
How is mean pulmonary artery pressure measured to calculate Pulmonary Vascular Resistance (PVR)?
What is the role of Open Reduction Internal Fixation (ORIF) in treating a patient with a complex or unstable facial fracture?
What is the recommended dose and administration of glimepiride (sulfonylurea) and metformin (biguanide) for a typical adult patient with type 2 diabetes mellitus (DM)?
What is the recommended immunosuppressive regimen for a patient undergoing kidney transplantation?
What is the next step in managing an elderly female patient with a history of metabolic disorders, encephalopathy, dysphasia, respiratory failure, diabetes, aphasia, CVA, depression, hyperlipidemia, TIA, heart failure, and hypertension, who recently recovered from COVID-19, has a G-tube in place, and presents with a potentially infected G-tube site, impaired renal function, and slightly elevated blood pressure, while on oxygen supplements and Bactroban dressing, with a history of MRSA?
What is the management plan for an adult patient with a liver stiffness measurement of 9.9 kPa, indicating significant liver fibrosis, and a history of liver disease, such as hepatitis or alcohol use disorder, diagnosed via liver ultrasound?
What is the next step in managing an 11-year-old female with a positive Antinuclear Antibody (ANA) test and titers of 1:40 and 1:80, but negative results for all other tests on the ANA panel?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.